Nephros Stock Financials

NEPH
 Stock
  

USD 0.93  0.02  2.20%   

We were able to interpolate data for thirty-five available fundamentals for Nephros, which can be compared to its peers in the industry. To ensure the equity is not overpriced, please verify all Nephros financials, including its debt to equity, market capitalization, and the relationship between the net income and short ratio . Given that Nephros is a hitting penny stock territory we strongly suggest to closely look at its number of shares shorted. Use Nephros to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Nephros to be traded at $1.116 in 90 days.
  
With this module, you can analyze Nephros financials for your investing period. You should be able to track the changes in Nephros individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Nephros Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Nephros' financial statements are interrelated, with each one affecting the others. For example, an increase in Nephros' assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Over 95
Nephros has more than 95 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Nephros stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Nephros' official financial statements usually reflect Nephros' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nephros. For example, before you start analyzing numbers published by Nephros accountants, it's critical to develop an understanding of what Nephros' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Nephros' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nephros' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nephros' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nephros. Please utilize our Beneish M Score to check the likelihood of Nephros' management to manipulate its earnings.

Nephros Company Summary

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. Nephros operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address380 Lackawanna Place
SectorHealthcare
IndustryMedical Instruments & Supplies
BenchmarkDOW
Websitewww.nephros.com
Phone201 343 5202
CurrencyUSD - US Dollar
You should never invest in Nephros without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nephros Stock, because this is throwing your money away. Analyzing the key information contained in Nephros' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Nephros Key Financial Ratios

Generally speaking, Nephros' financial ratios allow both analysts and investors to convert raw data from Nephros' financial statements into concise, actionable information that can be used to evaluate the performance of Nephros over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Nephros reports annually and quarterly.

Nephros Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nephros's current stock value. Our valuation model uses many indicators to compare Nephros value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nephros competition to find correlations between indicators driving Nephros's intrinsic value. More Info.
Nephros is considered to be number one stock in price to book category among related companies. It is considered to be number one stock in z score category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nephros by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nephros' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nephros' earnings, one of the primary drivers of an investment's value.

Nephros Systematic Risk

Nephros' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nephros volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Nephros correlated with the market. If Beta is less than 0 Nephros generally moves in the opposite direction as compared to the market. If Nephros Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nephros is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nephros is generally in the same direction as the market. If Beta > 1 Nephros moves generally in the same direction as, but more than the movement of the benchmark.
.

About Nephros Financials

What exactly are Nephros Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Nephros' income statement, its balance sheet, and the statement of cash flows. Potential Nephros investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Nephros investors may use each financial statement separately, they are all related. The changes in Nephros's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nephros's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Nephros is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Nephros has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Nephros October 4, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Nephros help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nephros. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nephros based on widely used predictive technical indicators. In general, we focus on analyzing Nephros Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nephros's daily price indicators and compare them against related drivers.
Information Ratio(0.18)
Maximum Drawdown25.15
Value At Risk(5.30)
Potential Upside4.73
Additionally, see Correlation Analysis. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for analysis

When running Nephros price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine Nephros value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.